Categories Cannabis, Earnings

Neptune Wellness (NASDAQ: NEPT): Q3 2020 Earnings Snapshot

— Neptune Wellness Solutions Inc. (NASDAQ: NEPT) swung to a profit in the third quarter of 2020 from a loss last year, helped by a gain related to a reduction in the fair value of the contingent consideration in connection to SugarLeaf Labs purchase.

— Total revenues jumped by 40% year-over-year to CAD9.18 million. This was driven by the cannabis segment despite a decline in the nutraceutical segment.

Earnings Update by AlphaStreet

— Revenue from the cannabis segment reached CAD2.81 million. The company started the commercial operations of its Cannabis segment in March 2019.

— Revenue from the nutraceutical segment declined by 3% to CAD6.34 million.

— The adjusted EBITDA loss widened from last year, due to the investments made in the cannabis segment to grow the workforce in anticipation of increased sales volume as well as higher salaries and benefits at the corporate level.

— The company launched its hemp-derived wellness products, Forest Remedies and Ocean Remedies, in the US. A similar launch in Canada will be followed once approved by health authorities.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top